Activin and Inhibin

KA2507 is a potent, orally active and selective HDAC6 inhibitor, with an IC 50 of 2.5 nM. KA2507 shows antitumor activities and immune modulatory effects in preclinical modelsIn VitroKA2507 did not inhibit the in vitro proliferation of mouse or

KA2507 is a potent, orally active and selective HDAC6 inhibitor, with an IC 50 of 2.5 nM. KA2507 shows antitumor activities and immune modulatory effects in preclinical modelsIn VitroKA2507 did not inhibit the in vitro proliferation of mouse or

In VivoKadsurenone (i.v.: 20 and 30 mg/kg) undergoes hepatobiliary excretion but might not be regulated by P-glycoprotein (P-gp) transported system . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In VivoKadsurenone (i.v.: 20 and 30 mg/kg) undergoes hepatobiliary excretion but might not be regulated by P-glycoprotein (P-gp) transported system . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Kaempferol-7-O-rhamnoside, isolated from Chimonanthus nitens Oliv. Leaves, is a potent α-glucosidase activity inhibitor. Kaempferol-7-O-rhamnoside has the potential for diabetesForm:SolidIC50&amp: Target:α-glucosidase activity.

KAG-308 is a potent selective and orally active agonist of EP4 receptor (a prostaglandin E2 receptor subtype), suppresses colitis and promotes histological mucosal healing, potently inhibits TNF-α production. KAG-308 shows a K i and an EC 50 of 2.57

KAG-308 is a potent selective and orally active agonist of EP4 receptor (a prostaglandin E2 receptor subtype), suppresses colitis and promotes histological mucosal healing, potently inhibits TNF-α production. KAG-308 shows a K i and an EC 50 of 2.57

Kamebakaurin is a natural compound isolated from Rabdosia excisa. Kamebakaurin is a potent inhibitor of NF-κB activation by directly targeting DNA-binding activity of p50.Form:Solid.

Kamebakaurin is a natural compound isolated from Rabdosia excisa. Kamebakaurin is a potent inhibitor of NF-κB activation by directly targeting DNA-binding activity of p50.Form:Solid.

Karenitecin (Cositecan) is a topoisomerase I inhibitor, with potent anti-cancer activity.In VitroKarenitecin is a topoisomerase I inhibitor, with potent anti-cancer activity. Karenitecin inhibits cell growth of A253 cells with IC 10 , IC 50 , and IC

Karenitecin (Cositecan) is a topoisomerase I inhibitor, with potent anti-cancer activity.In VitroKarenitecin is a topoisomerase I inhibitor, with potent anti-cancer activity. Karenitecin inhibits cell growth of A253 cells with IC 10 , IC 50 , and IC

KAT6-IN-1 is a potent KAT6 inhibitor. KAT6-IN-1 can be used in research of cancer.